Human adipose tissue is a putative direct target of daytime orexin with favorable metabolic effects: A cross‐sectional study

Orexin/hypocretin (Ox) and its receptors (OxR), a neuroendocrine system centrally regulating sleep/wakefulness, were implicated in the regulation of peripheral metabolism. It was hypothesized that human adipose tissue constitutes a direct target of the OxA/OxR system that associates with distinct metabolic profile(s).

[1]  C. D'souza,et al.  Hypocretin/orexin modulates body weight and the metabolism of glucose and insulin , 2020, Diabetes/metabolism research and reviews.

[2]  J. Pépin,et al.  Adipose tissue as a key player in obstructive sleep apnoea , 2019, European Respiratory Review.

[3]  A. Heagerty,et al.  Emerging Roles of Sympathetic Nerves and Inflammation in Perivascular Adipose Tissue , 2019, Cardiovascular Drugs and Therapy.

[4]  M. Mölle,et al.  Sleep Loss Disrupts Morning-to-Evening Differences in Human White Adipose Tissue Transcriptome. , 2018, The Journal of clinical endocrinology and metabolism.

[5]  M. Borga,et al.  Unexpected Fat Distribution in Adolescents With Narcolepsy , 2018, Front. Endocrinol..

[6]  K. Clément,et al.  Prediction of Long-Term Diabetes Remission After RYGB, Sleeve Gastrectomy, and Adjustable Gastric Banding Using DiaRem and Advanced-DiaRem Scores , 2018, Obesity Surgery.

[7]  S. Gammeltoft,et al.  Functional brown adipose tissue and sympathetic activity after cold exposure in humans with type 1 narcolepsy , 2018, Sleep.

[8]  J. Chen,et al.  The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases , 2018, Front. Mol. Neurosci..

[9]  M. Strowski,et al.  The role of orexin in controlling the activity of the adipo-pancreatic axis. , 2018, The Journal of endocrinology.

[10]  T. Sasaoka,et al.  Chronopathophysiological implications of orexin in sleep disturbances and lifestyle‐related disorders , 2017, Pharmacology & therapeutics.

[11]  M. Sassek,et al.  Chronic orexin-A (hypocretin-1) treatment of type 2 diabetic rats improves glucose control and beta-cell functions. , 2017, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[12]  L. Sparks,et al.  Investigating the effects of Orexin-A on thermogenesis in human deep neck brown adipose tissue , 2017, International Journal of Obesity.

[13]  I. Harman-boehm,et al.  ASK1 (MAP3K5) is transcriptionally upregulated by E2F1 in adipose tissue in obesity, molecularly defining a human dys-metabolic obese phenotype , 2017, Molecular metabolism.

[14]  T. Sakurai,et al.  Sleep Control, GPCRs, and Glucose Metabolism , 2016, Trends in Endocrinology & Metabolism.

[15]  I. Harman-boehm,et al.  Elevated autophagy gene expression in adipose tissue of obese humans: A potential non-cell-cycle-dependent function of E2F1 , 2015, Autophagy.

[16]  D. Song,et al.  Orexin A regulates plasma insulin and leptin levels in a time-dependent manner following a glucose load in mice , 2015, Diabetologia.

[17]  B. Banfield,et al.  Central sympathetic innervations to visceral and subcutaneous white adipose tissue. , 2014, American journal of physiology. Regulatory, integrative and comparative physiology.

[18]  C. Billington,et al.  Orexin modulation of adipose tissue. , 2014, Biochimica et biophysica acta.

[19]  C. Leonard,et al.  Orexin/hypocretin receptor signalling: a functional perspective , 2014, British journal of pharmacology.

[20]  C S Leonard,et al.  Orexin/hypocretin receptor signalling cascades , 2014, British journal of pharmacology.

[21]  J. Kukkonen.  Lipid signaling cascades of orexin/hypocretin receptors. , 2014, Biochimie.

[22]  X. Chang,et al.  Effects of orexin A on GLUT4 expression and lipid content via MAPK signaling in 3T3-L1 adipocytes , 2013, The Journal of Steroid Biochemistry and Molecular Biology.

[23]  E. Adeghate.  Orexins: tissue localization, functions, and its relation to insulin secretion and diabetes mellitus. , 2012, Vitamins and hormones.

[24]  L. Jonge,et al.  Chronic sleep deprivation and seasonality: Implications for the obesity epidemic , 2011, Journal of endocrinological investigation.

[25]  M. McCarthy,et al.  Comprehensive Human Adipose Tissue mRNA and MicroRNA Endogenous Control Selection for Quantitative Real‐Time‐PCR Normalization , 2011, Obesity.

[26]  T. Uhde,et al.  Low cerebrospinal fluid and plasma orexin-A (hypocretin-1) concentrations in combat-related posttraumatic stress disorder , 2010, Psychoneuroendocrinology.

[27]  M. Stumvoll,et al.  Activated Ask1-MKK4-p38MAPK/JNK stress signaling pathway in human omental fat tissue may link macrophage infiltration to whole-body Insulin sensitivity. , 2009, The Journal of clinical endocrinology and metabolism.

[28]  G. Kvalheim,et al.  Induction of Circadian Rhythm in Cultured Human Mesenchymal Stem Cells by Serum Shock and cAMP Analogs in Vitro , 2009, Chronobiology international.

[29]  K. Nagai,et al.  Biphasic effects of orexin-A on autonomic nerve activity and lipolysis , 2008, Neuroscience Letters.

[30]  K. Herzig,et al.  Functions of orexins in peripheral tissues , 2008, Acta physiologica.

[31]  Kathryn Moynihan Ramsey,et al.  High-fat diet disrupts behavioral and molecular circadian rhythms in mice. , 2007, Cell metabolism.

[32]  M. Stumvoll,et al.  Mitogen-activated protein kinases, inhibitory-kappaB kinase, and insulin signaling in human omental versus subcutaneous adipose tissue in obesity. , 2007, Endocrinology.

[33]  H. Randeva,et al.  Orexin receptor expression in human adipose tissue: effects of orexin-A and orexin-B. , 2006, The Journal of endocrinology.

[34]  C. Darimont,et al.  Reconstitution of telomerase activity combined with HPV-E7 expression allow human preadipocytes to preserve their differentiation capacity after immortalization , 2003, Cell Death and Differentiation.

[35]  W. Buurman,et al.  Decreased plasma orexin-A levels in obese individuals , 2002, International Journal of Obesity.

[36]  A. Kastin,et al.  Orexin A but not orexin B rapidly enters brain from blood by simple diffusion. , 1999, The Journal of pharmacology and experimental therapeutics.